Evan J Zasowski

2.2k total citations
49 papers, 1.6k citations indexed

About

Evan J Zasowski is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Evan J Zasowski has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 24 papers in Clinical Biochemistry and 16 papers in Epidemiology. Recurrent topics in Evan J Zasowski's work include Antimicrobial Resistance in Staphylococcus (28 papers), Bacterial Identification and Susceptibility Testing (24 papers) and Streptococcal Infections and Treatments (15 papers). Evan J Zasowski is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (28 papers), Bacterial Identification and Susceptibility Testing (24 papers) and Streptococcal Infections and Treatments (15 papers). Evan J Zasowski collaborates with scholars based in United States, Italy and United Kingdom. Evan J Zasowski's co-authors include Michael J. Rybak, Abdalhamid M Lagnf, Susan L. Davis, Trang D Trinh, Kimberly C. Claeys, Ryan P. Mynatt, Jeffrey M. Rybak, Jason M. Pogue, Natalie A. Finch and Kyle P. Murray and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Evan J Zasowski

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan J Zasowski United States 19 883 726 632 468 463 49 1.6k
Kimberly C. Claeys United States 24 535 0.6× 429 0.6× 596 0.9× 527 1.1× 427 0.9× 103 1.4k
Lawrence V. Friedrich United States 24 741 0.8× 807 1.1× 539 0.9× 603 1.3× 686 1.5× 58 1.9k
John Mohr United States 21 721 0.8× 378 0.5× 369 0.6× 472 1.0× 287 0.6× 49 1.5k
Katie E. Barber United States 21 827 0.9× 405 0.6× 421 0.7× 471 1.0× 371 0.8× 89 1.5k
Jeffrey Graves United States 8 860 1.0× 467 0.6× 685 1.1× 363 0.8× 239 0.5× 9 1.3k
Kenneth Klinker United States 19 575 0.7× 436 0.6× 369 0.6× 494 1.1× 189 0.4× 42 1.1k
Eileen Graffunder United States 11 772 0.9× 268 0.4× 649 1.0× 385 0.8× 353 0.8× 16 1.5k
Abdalhamid M Lagnf United States 18 468 0.5× 307 0.4× 343 0.5× 317 0.7× 366 0.8× 43 937
Ryan P. Mynatt United States 17 730 0.8× 633 0.9× 483 0.8× 299 0.6× 203 0.4× 37 1.1k
Alison Meagher United States 16 799 0.9× 1.0k 1.4× 471 0.7× 475 1.0× 709 1.5× 23 1.6k

Countries citing papers authored by Evan J Zasowski

Since Specialization
Citations

This map shows the geographic impact of Evan J Zasowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan J Zasowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan J Zasowski more than expected).

Fields of papers citing papers by Evan J Zasowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan J Zasowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan J Zasowski. The network helps show where Evan J Zasowski may publish in the future.

Co-authorship network of co-authors of Evan J Zasowski

This figure shows the co-authorship network connecting the top 25 collaborators of Evan J Zasowski. A scholar is included among the top collaborators of Evan J Zasowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan J Zasowski. Evan J Zasowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caffrey, Aisling R., Haley J. Appaneal, Vrishali V. Lopes, et al.. (2025). Association between nirmatrelvir/ritonavir treatment and antibiotic prescribing in the outpatient setting among patients with COVID-19. Microbiology Spectrum. 13(4). e0320924–e0320924. 1 indexed citations
2.
Appaneal, Haley J., Vrishali V. Lopes, Laura Puzniak, et al.. (2025). Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System. Nature Communications. 16(1). 4033–4033. 4 indexed citations
3.
Appaneal, Haley J., Kerry L. LaPlante, Vrishali V. Lopes, et al.. (2024). Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious Diseases and Therapy. 13(1). 155–172. 8 indexed citations
4.
Caffrey, Aisling R., Haley J. Appaneal, Vrishali V. Lopes, et al.. (2024). Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System. Nature Communications. 15(1). 9490–9490. 12 indexed citations
5.
Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2022). International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections. Infectious Diseases and Therapy. 11(6). 2253–2263. 6 indexed citations
6.
Carlson, Travis J, et al.. (2021). Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use. Open Forum Infectious Diseases. 8(10). ofab419–ofab419. 5 indexed citations
7.
Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2021). Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open Forum Infectious Diseases. 9(3). ofab606–ofab606. 18 indexed citations
8.
McCreary, Erin K, Ravina Kullar, Matthew Geriak, et al.. (2020). Multicenter Cohort of Patients With Methicillin-Resistant. 7(1). 538. 1 indexed citations
9.
Bassetti, Matteo, Jordi Rello, Francesco Blasi, et al.. (2020). Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections. International Journal of Antimicrobial Agents. 56(6). 106184–106184. 63 indexed citations
10.
Jorgensen, Sarah C J, Evan J Zasowski, Trang D Trinh, et al.. (2019). Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study. Clinical Infectious Diseases. 71(1). 1–10. 72 indexed citations
11.
McCreary, Erin K, Ravina Kullar, Matthew Geriak, et al.. (2019). Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments. Open Forum Infectious Diseases. 7(1). ofz538–ofz538. 65 indexed citations
12.
Jorgensen, Sarah C J, Trang D Trinh, Evan J Zasowski, et al.. (2019). 2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Open Forum Infectious Diseases. 6(Supplement_2). S769–S769. 6 indexed citations
13.
Trinh, Trang D, Sarah C J Jorgensen, Evan J Zasowski, et al.. (2019). Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 63(11). 4 indexed citations
14.
Trinh, Trang D, Evan J Zasowski, Kimberly C. Claeys, et al.. (2018). Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections. Infectious Diseases and Therapy. 7(1). 161–169. 6 indexed citations
15.
Avery, Lindsay M., Joseph L. Kuti, Maja Weisser, et al.. (2018). Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint. Clinical Infectious Diseases. 68(10). 1650–1657. 43 indexed citations
16.
Claeys, Kimberly C., Evan J Zasowski, Trang D Trinh, et al.. (2017). Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis. Infectious Diseases and Therapy. 7(1). 135–146. 17 indexed citations
17.
Lodise, Thomas P., Monique R. Bidell, Shawn D. Flanagan, et al.. (2016). Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy. 71(9). 2553–2558. 33 indexed citations
18.
Zasowski, Evan J, Kimberly C. Claeys, Abdalhamid M Lagnf, Susan L. Davis, & Michael J. Rybak. (2016). Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections. Clinical Infectious Diseases. 62(10). 1242–1250. 100 indexed citations
19.
Lodise, Thomas P., George L. Drusano, Evan J Zasowski, et al.. (2014). Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?. Clinical Infectious Diseases. 59(5). 666–675. 124 indexed citations
20.
Zasowski, Evan J, Christopher M. Bland, Vincent H. Tam, & Thomas P. Lodise. (2014). Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients. Journal of Antimicrobial Chemotherapy. 70(3). 877–881. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026